Cardiac

Roche has led the way in cardiac care with innovative biomarkers focused on reducing the burden of cardiovascular disease for patients and society.

Roche pioneered the development of high sensitivity Troponin T STAT and NT-proBNP. Since its global launch in 2009, Troponin T Gen 5 has amassed over 900 peer reviewed articles and NT-proBNP has been recognized as the Gold Standard in HF with 15 years of evidence generation. ^1-3

References

1 McKie, PM., Burnett, JC. Jr. (2016). J Am Coll Cardiol 6, 68(22), 2437-2439.

2 Francis, et al. (2016). J Am Coll CArdil. 67(3):330–337.

3 PubMed Central®: search results for “NT-proBNP heart failure” retrieved on https://www.ncbi.nlm.nih.gov/pubmed/?term=NT-proBNP+heart+failure [Accessed on: 29th November 2017].